BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26091900)

  • 1. Identification and characterization of reactive metabolites in myristicin-mediated mechanism-based inhibition of CYP1A2.
    Yang AH; He X; Chen JX; He LN; Jin CH; Wang LL; Zhang FL; An LJ
    Chem Biol Interact; 2015 Jul; 237():133-40. PubMed ID: 26091900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of human liver cytochrome P450 3A4 and 1A2 enzymes in the oxidation of myristicin.
    Yun CH; Lee HS; Lee HY; Yim SK; Kim KH; Kim E; Yea SS; Guengerich FP
    Toxicol Lett; 2003 Feb; 137(3):143-50. PubMed ID: 12523956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and analysis of the reactive metabolites related to the hepatotoxicity of safrole.
    Yang AH; Zhang L; Zhi DX; Liu WL; Gao X; He X
    Xenobiotica; 2018 Nov; 48(11):1164-1172. PubMed ID: 29082813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myristicin from nutmeg induces apoptosis via the mitochondrial pathway and down regulates genes of the DNA damage response pathways in human leukaemia K562 cells.
    Martins C; Doran C; Silva IC; Miranda C; Rueff J; Rodrigues AS
    Chem Biol Interact; 2014 Jul; 218():1-9. PubMed ID: 24792648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro metabolism of 4, 5-dimethoxycanthin-6-one by human liver microsomes and its inhibition on human CYP1A2.
    Miao X; You J; Wang J; Chen Y
    Life Sci; 2017 Dec; 190():46-51. PubMed ID: 28962866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myristicin-induced neurotoxicity in human neuroblastoma SK-N-SH cells.
    Lee BK; Kim JH; Jung JW; Choi JW; Han ES; Lee SH; Ko KH; Ryu JH
    Toxicol Lett; 2005 May; 157(1):49-56. PubMed ID: 15795093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Activation of Myristicin and Its Role in Cellular Toxicity.
    Zhu X; Wang YK; Yang XN; Xiao XR; Zhang T; Yang XW; Qin HB; Li F
    J Agric Food Chem; 2019 Apr; 67(15):4328-4336. PubMed ID: 30912427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro inhibitory effect of piperlonguminine isolated from Piper longum on human cytochrome P450 1A2.
    Song M; Hwang JY; Lee MY; Jee JG; Lee YM; Bae JS; Kim JA; Lee SH; Lee S
    Arch Pharm Res; 2014 Aug; 37(8):1063-8. PubMed ID: 24194261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of myristicin by Depressaria pastinacella CYP6AB3v2 and inhibition by its metabolite.
    Mao W; Zangerl AR; Berenbaum MR; Schuler MA
    Insect Biochem Mol Biol; 2008 Jun; 38(6):645-51. PubMed ID: 18510976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo metabolism of myristicin in the rat.
    Lee HS; Jeong TC; Kim JH
    J Chromatogr B Biomed Sci Appl; 1998 Feb; 705(2):367-72. PubMed ID: 9521577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity of safrole in HepaRG cells: studies on the role of CYP1A2-mediated ortho-quinone metabolic activation.
    Hu L; Wu F; He J; Zhong L; Song Y; Shao H
    Xenobiotica; 2019 Dec; 49(12):1504-1515. PubMed ID: 30865484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of rat hepatic cytochrome P450 enzymes by myristicin.
    Jeong HG; Yun CH
    Biochem Biophys Res Commun; 1995 Dec; 217(3):966-71. PubMed ID: 8554622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory effect of myristicin on RAW 264.7 macrophages stimulated with polyinosinic-polycytidylic acid.
    Lee JY; Park W
    Molecules; 2011; 16(8):7132-42. PubMed ID: 21991618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicological evaluation of myristicin.
    Hallström H; Thuvander A
    Nat Toxins; 1997; 5(5):186-92. PubMed ID: 9496377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibition of CYP1A2, CYP2C9, and CYP2D6 by pterostilbene in human liver microsomes.
    Albassam AA; Ahad A; Alsultan A; Yusufoglu HS; Foudah AI; Al-Jenoobi FI
    Pharmazie; 2021 Apr; 76(4):155-158. PubMed ID: 33849700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the anxiolytic properties of myristicin, a component of nutmeg, in the male Sprague-Dawley rat.
    Leiter E; Hitchcock G; Godwin S; Johnson M; Sedgwick W; Jones W; McCall S; Ceremuga TE
    AANA J; 2011 Apr; 79(2):109-14. PubMed ID: 21560973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Human Plasma Samples to Identify Circulating Drug Metabolites that Inhibit Cytochrome P450 Enzymes.
    Eng H; Obach RS
    Drug Metab Dispos; 2016 Aug; 44(8):1217-28. PubMed ID: 27271369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologically based kinetic modeling of the bioactivation of myristicin.
    Al-Malahmeh AJ; Al-Ajlouni A; Wesseling S; Soffers AE; Al-Subeihi A; Kiwamoto R; Vervoort J; Rietjens IM
    Arch Toxicol; 2017 Feb; 91(2):713-734. PubMed ID: 27334372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential overexpression of a class MU glutathione S-transferase subunit in mouse liver by myristicin.
    Ahmad H; Tijerina MT; Tobola AS
    Biochem Biophys Res Commun; 1997 Jul; 236(3):825-8. PubMed ID: 9245741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of benzo[a]pyrene-induced tumorigenesis by myristicin, a volatile aroma constituent of parsley leaf oil.
    Zheng GQ; Kenney PM; Zhang J; Lam LK
    Carcinogenesis; 1992 Oct; 13(10):1921-3. PubMed ID: 1423855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.